Seqens Seqens

X

Digital content for Azafaros

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Azafaros
Netherlands1 Flag
Country
Country
Netherlands
Address
Address
J.H. Oortweg 21 2333 CH Leiden The Netherlands
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.globenewswire.com//news-release/2024/03/12/2844274/0/en/Azafaros-announces-completion-of-12-week-Phase-2-RAINBOW-study-evaluating-lead-asset-nizubaglustat-in-rare-disease-patients.html

GLOBENEWSWIRE
12 Mar 2024

https://www.globenewswire.com//news-release/2024/01/23/2813683/0/en/Azafaros-to-present-data-from-PRONTO-study-in-patients-with-GM1-and-GM2-gangliosidoses-at-the-20th-annual-WORLDSymposium.html

GLOBENEWSWIRE
22 Jan 2024

https://www.globenewswire.com//news-release/2023/12/11/2793532/0/en/Azafaros-Phase-2-RAINBOW-study-evaluating-nizubaglustat-in-GM2-and-NPC-patients-is-now-fully-enrolled.html

GLOBENEWSWIRE
11 Dec 2023

https://www.businesswire.com/news/home/20230608005099/en

BUSINESSWIRE
08 Jun 2023

https://www.businesswire.com/news/home/20230320005053/en

BUSINESSWIRE
20 Mar 2023

https://www.businesswire.com/news/home/20230220005101/en/Azafaros-Receives-Additional-Regulatory-Designations-for-AZ-3102-from-FDA-EMA-and-MHRA

BUSINESSWIRE
21 Feb 2023

https://www.businesswire.com/news/home/20230109005400/en

BUSINESSWIRE
09 Jan 2023

https://www.businesswire.com/news/home/20230105005488/en

BUSINESSWIRE
05 Jan 2023

https://www.businesswire.com/news/home/20220324005489/en

BUSINESSWIRE
24 Mar 2022

https://www.businesswire.com/news/home/20220214005364/en

BUSINESSWIRE
14 Feb 2022
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY